Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis

Clin Lymphoma Myeloma Leuk. 2016 Jul;16(7):e109-12. doi: 10.1016/j.clml.2016.04.013. Epub 2016 May 5.

Authors

Marie-Charlotte Veys¹, Michel Delforge², Ilse Mombaerts³

Affiliations

¹ Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
² Department of Hematology, University Hospitals Leuven, Leuven, Belgium.
³ Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium. Electronic address: Ilse.mombaerts@uzleuven.be.

PMID: 27349766
DOI: 10.1016/j.clml.2016.04.013

No abstract available

Keywords: Eyelid disease; Management; Multiple myeloma; Quality of life; Velcade.

Publication types

Case Reports

MeSH terms

Aged
Blepharitis / chemically induced*
Blepharitis / drug therapy*
Bortezomib / adverse effects*
Doxycycline / therapeutic use*
Female
Humans
Paraproteinemias / drug therapy

Substances

Bortezomib
Doxycycline